Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Rapid androgen cycling as treatment for patients with prostate cancerDavid Feltquate, Luke Nordquist, Caitlin Eicher, et al.Surgical Oncology|April 18, 2026
Comparative perioperative and early oncologic outcomes of robot-assisted versus open retroperitoneal lymph node dissection in testicular germ cell tumors-experience from a tertiary Latin American referral centerWilly Baccaglini, Luis G Medina, Julio Calderon, et al.Clinical Genitourinary Cancer|February 21, 2021
Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV StudyFernando C Maluf, Fabrício A M de Oliveira, Pedro E R Liedke, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|November 2, 2016
Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysisArie Carneiro, Willy Baccaglini, Felipe P A Glina, et al.Clinics (Sao Paulo, Brazil)|October 13, 2021
Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapyLaura Testa, Max Mano, Roberto Jun Arai, et al.Einstein (Sao Paulo, Brazil)|July 9, 2015
The impact of erlotinib use in non-small-cell lung cancer patients treated in a private reference general hospital and in a private cancer clinic from 2005 to 2011Cinthia Leite Frizzera Borges Bognar, Sergio Daniel Simon, Rene Claudio Gansl, et al.Einstein (Sao Paulo, Brazil)|August 28, 2015
Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is deliveredPedro Luiz Serrano Usón Junior, Monique Sedlmaier França, Heloisa Veasey Rodrigues, et al.Cancer|April 28, 2004
High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMichael J Morris, Oren Smaletz, David Solit, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|October 17, 2018
Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancerPaulo Priante Kayano, Arie Carneiro, Tiago Mendonça Lopez Castilho, et al.BMC Cancer|May 25, 2019
The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levelsGustavo Werutsky, Fernando Cotait Maluf, Eduardo Henrique Cronemberger, et al.Pageof 4